Tramadol inhibits the contractility of isolated human myometrium

Autonomic and Autacoid Pharmacology

Volumn 33, Issue 1-2, 2013, Pages 1-5

  Shah, N H ^a   Thomas, E ^a   Jose, R ^a   Peedicayil, J ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Contractility; Human; Isolated; Myometrium; Tramadol

Indexed keywords

METHYLENE BLUE; NALOXONE; POTASSIUM CHLORIDE; PROPRANOLOL; TRAMADOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; UTERUS CONTRACTILITY; UTERUS RELAXATION;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; FEMALE; GUANYLATE CYCLASE; HUMANS; ISOPROTERENOL; METHYLENE BLUE; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; NITRIC OXIDE SYNTHASE; POTASSIUM CHLORIDE; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA-1; TRAMADOL; UTERINE CONTRACTION;

EID: 84875667332     PISSN: 14748665     EISSN: 14748673     Source Type: Journal    
DOI: 10.1111/aap.12003     Document Type: Article

References (20)

1. Bzoskie, L., Blount, L., Kashiwai, K., Humme, J. & Padbury, J.F. (1997). The contribution of transporter-dependent uptake to fetal catecholamine clearance. Biol. Neonate, 71, 102-110.
2. 3-adrenoceptor agonists: human myometrial selectivity and effects on umbilical artery tone. Am. J. Obstet. Gynecol., 187, 641-647.
3. Elbourne, D. & Wiseman, R.A. (2000). Types of intra-muscular opioids for maternal pain relief in labour. Cochrane Database Syst. Rev., 2, CD001237.
4. Goeringer, K.E., Logan, B.K. & Christian, G.D. (1997). Identification of tramadol and its metabolites in blood from drug-related deaths and drug-impaired drivers. J. Anal. Toxicol., 21, 529-537.
5. Grond, S. & Sablotztki, A. (2004). Clinical pharmacology of tramadol. Clin. Pharmacokinet., 43, 879-923.
6. Herbert, M.K., Weis, R. & Holzer, P. (2007). The enantiomers of tramadol and its major metabolite inhibit peristalsis in the guinea pig small intestine via differential mechanisms. BMC Pharmacol., 7, 5.
7. Kaya, T., Gursoy, S., Karadas, B., Sarac, B., Kafali, H. & Soydan, A.S. (2003). High-concentration tramadol-induced vasodilation in rabbit aorta is mediated by both endothelium-dependent and-independent mechanisms. Acta Pharmacol. Sin., 24, 385-389.
8. Kumar, A., Prabha, R., Paul, T., Shanthi, M., George, J., Peedicayil, J. & Ernest, K. (2012). Tramadol inhibits the contractility of isolated caprine detrusor muscle. Auton. Autacoid Pharmacol., 32, 15-22.
9. Leppert, W. (2009). Tramadol as an analgesic for mild to moderate cancer pain. Pharmacol. Rep., 61, 978-992.
10. Prabhakaran, S.S., Dhanasekar, K.R., Thomas, E., Jose, R., Peedicayil, J. & Samuel, P. (2010). Inhibition of isolated human myometrium contractility by minoxidil and reversal by glibenclamide. Methods Find. Exp. Clin. Pharmacol., 32, 97-100.
11. Rang, H.P., Dale, M.M., Ritter, J.M., Flower, R.J. & Henderson, G. (2012). Noradrenergic transmission. In: Rang and Dale's Pharmacology. (Eds H.P. Rang, M.M. Dale, J.M. Ritter, R.J. Flower & G. Henderson ), pp. 174-193. Elsevier, Edinburgh.
12. Reeves, R.R. & Burke, R.S. (2008). Tramadol: basic pharmacology and emerging concepts. Drugs Today, 44, 827-836.
13. 3-adrenoceptor is the predominant ß-adrenoceptor subtype in human myometrium and its expression is up-regulated in pregnancy. J. Clin. Endocrinol. Metab., 90, 1644-1650.
14. Sagata, K., Minami, K., Yanagihara, N., Shiraishi, M., Toyohira, Y., Ueno, S. & Shigematsu, A. (2002). Tramadol inhibits norepinephrine transporter function at desipramine-binding sites in cultured bovine adrenal medullary cells. Anesth. Analg., 94, 901-906.
15. Scott, L.J. & Perry, C.M. (2000). Tramadol: a review of its use in perioperative pain. Drugs, 60, 139-176.
16. Shadnia, S., Soltaninejad, K., Heydari, K., Sasanian, G. & Abdollahi, M. (2008). Tramadol intoxication: a review of 114 cases. Hum. Exp. Toxicol., 27, 201-205.
17. 3 receptors. Anesth. Analg., 95, 1269-1273.
18. 1 receptors. J. Pharmacol. Exp. Ther., 299, 255-260.
19. 3-adrenergic receptor. Annu. Rev. Pharmacol. Toxicol., 37, 421-450.
20. 2: a human whole-body PET study. Eur. J. Nucl. Med. Mol. Imaging, 35, 630-636.